We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Evaluates therapeutic efficacy of selpercatinib in early-stage RET fusion-positive lung cancer, suggesting improved outcomes.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: